PMC:7164862 / 1957-2300 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"78","span":{"begin":126,"end":136},"obj":"Species"},{"id":"79","span":{"begin":218,"end":228},"obj":"Species"},{"id":"85","span":{"begin":39,"end":50},"obj":"Chemical"},{"id":"95","span":{"begin":94,"end":103},"obj":"Disease"},{"id":"96","span":{"begin":317,"end":326},"obj":"Disease"},{"id":"97","span":{"begin":334,"end":342},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"Tax:2697049"},{"id":"A79","pred":"tao:has_database_id","subj":"79","obj":"Tax:2697049"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"MESH:D002738"},{"id":"A95","pred":"tao:has_database_id","subj":"95","obj":"MESH:D007239"},{"id":"A96","pred":"tao:has_database_id","subj":"96","obj":"MESH:D003643"},{"id":"A97","pred":"tao:has_database_id","subj":"97","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":94,"end":103},"obj":"Disease"},{"id":"T20","span":{"begin":126,"end":134},"obj":"Disease"},{"id":"T21","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"T22","span":{"begin":334,"end":342},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":25,"end":30},"obj":"Chemical"},{"id":"T17","span":{"begin":39,"end":50},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":343},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T42","span":{"begin":25,"end":30},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T43","span":{"begin":39,"end":50},"obj":"CHEBI:3638;CHEBI:3638;DG_10"},{"id":"T44","span":{"begin":126,"end":136},"obj":"SP_7"},{"id":"T45","span":{"begin":218,"end":228},"obj":"SP_7"},{"id":"T46","span":{"begin":334,"end":342},"obj":"SP_7"},{"id":"T21911","span":{"begin":25,"end":30},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T43631","span":{"begin":39,"end":50},"obj":"CHEBI:3638;CHEBI:3638;DG_10"},{"id":"T72889","span":{"begin":126,"end":136},"obj":"SP_7"},{"id":"T29038","span":{"begin":218,"end":228},"obj":"SP_7"},{"id":"T67579","span":{"begin":334,"end":342},"obj":"SP_7"}],"text":"In both cases, effective drugs such as chloroquine and its related formulations might prevent infection (ie, in those who are SARS-CoV-2 negative) or the development of severe symptomatic disease (ie, in those who are SARS-CoV-2 positive and asymptomatic or with minor symptoms), substantially reducing morbidity and mortality due to COVID-19."}